Comparing new vs. old criteria for diagnosing multiple sclerosis
Part of Brain & nervous system, Immune system & allergy clinical trials.
This trial compares two sets of diagnostic criteria (McDonald criteria 2024 vs. 2017) for multiple sclerosis in real-life settings. It aims to see which criteria work better in diagnosing MS in patients with symptoms or MRI findings that suggest the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be covered by French national health insurance.
- You must be seen at Nancy University Hospital or Metz-Thionville Regional Hospital (Mercy site) for the first time with symptoms or MRI findings that might be multiple sclerosis.
- Your doctor must think your symptoms or MRI findings could be multiple sclerosis.
- You cannot have symptoms or MRI findings that suggest another condition like neuromyelitis optica, anti-MOG disorders, sarcoidosis, or other causes such as infections or tumors.
- You must be able to have at least one brain MRI (no medical reason that prevents it).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether MS relapses happen without any signs of new disease activity on an MRI scan. By tracking your symptoms and scans, researchers hope to better understand how MS affects people in real life. If you qualify, you may help improve future treatment decisions.
This study screens for cognitive problems (like memory or thinking issues) in people with multiple sclerosis. It aims to identify these issues early so they can be managed better.
This trial uses brain MRI and eye imaging tests to study research markers in people with multiple sclerosis (MS) and related neurologic conditions. It may help researchers better understand these diseases and how they change over time.
This study looks at how certain brain changes relate to disability in people with multiple sclerosis (MS). It aims to see if measuring brain volume loss can help predict disease progression, which might help tailor treatments.
This study uses advanced MRI scans to see if they can provide more detailed brain images for people with multiple sclerosis (MS) and healthy volunteers. The goal is to improve how doctors monitor MS and understand brain changes.
This study looks at people with multiple sclerosis (MS) who also have functional neurological disorder (FND), which are symptoms like weakness or tremors that are not caused by MS damage. The goal is to learn more about these symptoms and what might be linked to them, which could help improve care.
Hear when a new Multiple sclerosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.